Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Getting control of intestinal secretion: thoughts for 2003.

M J G Farthing1, A Casburn-Jones, M R Banks

  • 1Faculty of Medicine, University of Glasgow, Glasgow G12 8QQ, UK. m.farthing@clinmed.gla.ac.uk

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
|July 19, 2003
PubMed
Summary

Researchers are developing new anti-secretory therapies to reduce stool volume in patients with watery diarrhea. These novel treatments target neurohumoral mechanisms and offer hope for more effective diarrhea management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus.

Lasers in medical science·2012
Same author

Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy.

Endoscopy·2011
Same author

Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy.

British journal of cancer·2010
Same author

Can global guidelines change health policy?

Nature clinical practice. Gastroenterology & hepatology·2007
Same author

Is an evidence-based approach to creating guidelines always the right one?

Nature clinical practice. Gastroenterology & hepatology·2007
Same author

Are global guidelines desirable, feasible and necessary?

Nature clinical practice. Gastroenterology & hepatology·2007

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Diarrhea treatment has long sought agents to inhibit intestinal secretion and reduce stool volume.
  • Neurohumoral mechanisms, including 5-hydroxytryptamine (serotonin), substance P, and vasoactive intestinal polypeptide, are implicated in diarrhea pathogenesis.
  • Enteric nervous system reflexes and enterotoxins like cholera toxin play a role in diarrheal states.

Purpose of the Study:

  • To explore novel anti-secretory therapeutic targets for high-volume watery diarrhea.
  • To investigate the potential of targeting neurohumoral pathways in the gut.

Main Methods:

  • Review of recent research on intestinal pathophysiology and neurohumoral mechanisms in diarrhea.
  • Identification of potential therapeutic targets based on understanding these mechanisms.

Related Experiment Videos

Main Results:

  • Neurohumoral pathways are key targets for anti-secretory therapy.
  • Potential drug targets include 5-hydroxytryptamine receptor antagonists, substance P antagonists, vasoactive intestinal polypeptide antagonists, and enkephalinase inhibitors.
  • Enkephalinase inhibitors may enhance the absorption-promoting effects of enkephalins.

Conclusions:

  • Novel anti-secretory therapies targeting neurohumoral mechanisms show promise for managing watery diarrhea.
  • The development of these agents could lead to more widely available and effective treatments in the future.